TCL Archive GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile August 30, 2013
TCL Archive Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients November 29, 2002
TCL Archive IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies May 8, 1987
TCL Archive In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval March 15, 1991